These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10205619)

  • 21. Metabolism of 1,1-dichloro-cis-diphenylcyclopropane by rat liver microsomes.
    Caputo O; Grosa G; Ceruti M; Rocco F; Biglino G
    Drug Metab Dispos; 1990; 18(5):771-8. PubMed ID: 1981735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of tamoxifen and its metabolite alpha-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytes.
    Phillips DH; Carmichael PL; Hewer A; Cole KJ; Hardcastle IR; Poon GK; Keogh A; Strain AJ
    Carcinogenesis; 1996 Jan; 17(1):89-94. PubMed ID: 8565142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of inhibitors on the biotransformation of tamoxifen by female rat and mouse liver slices and homogenates.
    Jordan CG; Brown K; Beedham C; Brown JE
    Drug Metabol Drug Interact; 1999; 15(4):239-58. PubMed ID: 10716039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-hydroxytamoxifen is a substrate of hydroxysteroid (alcohol) sulfotransferase, resulting in tamoxifen DNA adducts.
    Shibutani S; Dasaradhi L; Terashima I; Banoglu E; Duffel MW
    Cancer Res; 1998 Feb; 58(4):647-53. PubMed ID: 9485016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo.
    Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K
    Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen.
    Pathak DN; Pongracz K; Bodell WJ
    Carcinogenesis; 1996 Sep; 17(9):1785-90. PubMed ID: 8824496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quaternary ammonium-linked glucuronidation of trans-4-hydroxytamoxifen, an active metabolite of tamoxifen, by human liver microsomes and UDP-glucuronosyltransferase 1A4.
    Ogura K; Ishikawa Y; Kaku T; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
    Biochem Pharmacol; 2006 Apr; 71(9):1358-69. PubMed ID: 16480962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site-specific tamoxifen-DNA adduct formation: lack of correlation with mutational ability in Escherichia coli.
    Lowes DA; Brown K; Heydon RT; Martin EA; Gant TW
    Biochemistry; 1999 Aug; 38(34):10989-96. PubMed ID: 10460153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-hydroxytamoxifen, a genotoxic metabolite of tamoxifen in the rat: identification and quantification in vivo and in vitro.
    Boocock DJ; Maggs JL; White IN; Park BK
    Carcinogenesis; 1999 Jan; 20(1):153-60. PubMed ID: 9934863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of tamoxifen-DNA adducts on lacI genes using DNA polymerase stop assay.
    Cheng RH; Gant TW
    Changgeng Yi Xue Za Zhi; 1999 Jun; 22(2):189-96. PubMed ID: 10493022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the major tamoxifen-DNA adducts in rat liver by mass spectroscopy.
    Rajaniemi H; Rasanen I; Koivisto P; Peltonen K; Hemminki K
    Carcinogenesis; 1999 Feb; 20(2):305-9. PubMed ID: 10069469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen.
    Osborne MR; Hewer A; Hardcastle IR; Carmichael PL; Phillips DH
    Cancer Res; 1996 Jan; 56(1):66-71. PubMed ID: 8548777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenicity of tamoxifen DNA adducts in human endometrial cells and in silico prediction of p53 mutation hotspots.
    Liapis E; McLuckie KI; Lewis PD; Farmer PB; Brown K
    Nucleic Acids Res; 2008 Oct; 36(18):5933-45. PubMed ID: 18805907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of the cis and trans isomers of N-nitroso-2,6-dimethylmorpholine and their deuterated analogs by liver microsomes of rat and hamster.
    Kokkinakis D; Hollenberg PF; Scarpelli DG
    Carcinogenesis; 1984 Aug; 5(8):1009-14. PubMed ID: 6744510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of tamoxifen-DNA adducts induced by alpha-acetoxy-N-desmethyltamoxifen.
    Kitagawa M; Ravindernath A; Suzuki N; Rieger R; Terashima I; Umemoto A; Shibutani S
    Chem Res Toxicol; 2000 Aug; 13(8):761-9. PubMed ID: 10956064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
    Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
    Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reverse geometrical selectivity in glucuronidation and sulfation of cis- and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases.
    Nishiyama T; Ogura K; Nakano H; Ohnuma T; Kaku T; Hiratsuka A; Muro K; Watabe T
    Biochem Pharmacol; 2002 May; 63(10):1817-30. PubMed ID: 12034366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes.
    Lim CK; Yuan ZX; Lamb JH; White IN; De Matteis F; Smith LL
    Carcinogenesis; 1994 Apr; 15(4):589-93. PubMed ID: 8149466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,25-Dihydroxyvitamin D synthesis in rat liver microsomes.
    Negrea LA; Slatopolsky E; Dusso AS
    Horm Metab Res; 1995 Oct; 27(10):461-4. PubMed ID: 8575725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcellular localization of triphenylethylene antiestrogen binding sites (TABS) in rat liver.
    Clark JH; Guthrie S
    J Steroid Biochem; 1986 Nov; 25(5A):635-9. PubMed ID: 2432354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.